News

Gladstone in the News October 6, 2020

Doudna Inc.: How Cal Scientist Created a Biotech Startup Engine

San Francisco Business Times—As Scribe Therapeutics Inc., the latest company founded by Senior Investigator Jennifer Doudna, PhD, announced that it landed a deal with Biogen Inc., Gladstone President Deepak Srivastava, MD, commented on the importance of CRISPR-based biotech companies for medicine and agriculture and on Doudna’s drive as a scientist.

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing

Gladstone in the News June 27, 2020

A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys

The New York Times—Gladstone President Deepak Srivastava, MD, and Senior Investigator Jennifer Doudna, PhD, comment on a recent report of the successful use of novel CRISPR technology to lower cholesterol and triglyceride levels in monkeys.

Gladstone Experts Heart Failure Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing Disease Models

Gladstone in the News May 29, 2020

Inspire Awards: Jennifer Doudna Transforms UC Berkeley Lab to Process COVID-19 Tests

San Francisco Business Times—Early on in the pandemic, Gladstone Senior Investigator Jennifer Doudna, PhD, co-discoverer of CRISPR, recognized the need for safe, reliable, and rapid COVID-19 testing. She quickly mobilized a team of scientists from UC Berkeley, UC San Francisco, and elsewhere to develop a high-throughput detection assay and test vulnerable and at-risk populations in the Bay Area. Doudna was recently named one of the most influential women in Bay Area business by the San Francisco Business Times.

Womens Initiative Gladstone Experts COVID-19 Data Science and Biotechnology Doudna Lab

Gladstone in the News April 30, 2020

Gladstone Institutes Researchers Tackle Coronavirus with Robotics, Mobile Phone Technology

Engineering.com—Gladstone Senior Investigators Melanie Ott and Jennifer Doudna are collaborating with scientists across the Bay Area to develop a rapid COVID-19 testing platform that pairs CRISPR technology with a smartphone camera.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Article April 24, 2020

From HIV to COVID-19

Researchers who spent decades studying human immunodeficiency virus are using some of the same tools and approaches to tackle SARS-CoV-2, the virus that causes COVID-19.

Gladstone Experts COVID-19 HIV/AIDS Center for HIV Cure Research Virology Akassoglou Lab Doudna Lab Greene Lab Ott Lab

Gladstone in the News March 31, 2020

UC Berkeley Leads Team of Scientists to Open Advanced, ‘Pop-Up’ Coronavirus Testing Lab

San Francisco Chronicle—Senior Investigator Jennifer Doudna works in collaboration with over 200 researchers to ramp up coronavirus testing in the Bay Area's new "pop-up" genome research lab.

Gladstone Experts Doudna Lab

Gladstone in the News March 30, 2020

UC Berkeley Scientists Spin up a Robotic COVID-19 Testing Lab

Berkeley News—Gladstone Investigator Jennifer Doudna addresses the importance in the influx of coronavirus research in the Bay Area in finding solutions to the growing outbreak and those to come.

Gladstone Experts Doudna Lab

Gladstone in the News March 25, 2020

Gladstone Scientists Respond to Coronavirus Pandemic

The Stem Cellar—Gladstone Investigators Jennifer Doudna, Melanie Ott, Nevan Krogan, Warner Greene, and Leor Weinberger team up to develop an effective approach to diagnosis, treatment, and prevention of COVID-19.

Gladstone Experts Doudna Lab Greene Lab Krogan Lab Ott Lab Weinberger Lab

Article March 20, 2020

Gladstone Institutes Responds to COVID-19 Pandemic

In response to the COVID-19 pandemic, Gladstone scientists have rapidly pivoted the focus of their research labs to the novel virus, SARS-CoV-2.

Gladstone Experts News Release COVID-19 Cardiovascular Disease Genomic Immunology Virology Conklin Lab Doudna Lab Greene Lab Krogan Lab

Gladstone in the News March 18, 2020

UC Berkeley’s Doudna Named to Receive Vanderbilt Prize

VUMC—Jennifer Doudna was awarded the 2020 Vanderbilt Prize in Biomedical Science. The prize recognizes women scientists with an outstanding record of research accomplishments who have also made significant contributions to mentoring other women in science.

Gladstone Experts COVID-19 Doudna Lab

Gladstone in the News March 8, 2020

A Day with Jennifer Doudna: Trying to Keep up with One of the World’s Most Sought-After Scientists

C&EN—See what a normal day is like for world-renowned scientist and inventor of CRISPR technology, Jennifer Doudna.

Gladstone Experts Doudna Lab

Article January 24, 2020

Jennifer Doudna Wins the 2020 Wolf Prize in Medicine

The Wolf Foundation grants awards annually to celebrate scientists and artists from around the world whose work has made the world a better place.

Awards Data Science and Biotechnology Genomic Immunology Doudna Lab CRISPR/Gene Editing

Article November 25, 2019

Carving New Paths in the Fight against HIV

Gladstone scientists are taking a variety of approaches to find a cure for HIV

Gladstone Experts HIV/AIDS Center for HIV Cure Research Genomic Immunology Virology Doudna Lab Greene Lab Ott Lab Weinberger Lab

Article August 21, 2019

Gladstone Investigator Wins 2019 Prize for Contribution to World Civilization

Jennifer Doudna, the co-inventor of CRISPR genome editing technology, receives 2019 LUI Che Woo Prize for World Civilization.

Awards Data Science and Biotechnology Genomic Immunology Doudna Lab CRISPR/Gene Editing

Article November 26, 2018

Scientists Comment on Claim of Gene-Edited Babies

Gladstone investigators call for caution and ethical oversight

Gladstone Experts Data Science and Biotechnology Genomic Immunology Conklin Lab Doudna Lab McDevitt Lab CRISPR/Gene Editing